{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:15:31Z","timestamp":1787508931322,"version":"build-2736575974"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T00:00:00Z","timestamp":1565740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18H02822"],"award-info":[{"award-number":["18H02822"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16H04901"],"award-info":[{"award-number":["16H04901"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17H05654"],"award-info":[{"award-number":["17H05654"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology","award":["JPMJPR1537"],"award-info":[{"award-number":["JPMJPR1537"]}]},{"DOI":"10.13039\/501100007638","name":"Japan Kidney Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007638","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiorenal syndrome is a major cause of mortality in patients with chronic kidney disease (CKD). However, the involvement of detrimental humoral mediators in the pathogenesis of cardiorenal syndrome is still controversial. Trimethylamine-N-oxide (TMAO), a hepatic metabolic product of trimethylamine generated from dietary phosphatidylcholine or carnitine derived by the gut microbiota, has been linked directly with progression of cardiovascular disease and renal dysfunction. Thus, targeting TMAO may be a novel strategy for the prevention of cardiovascular disease and chronic kidney disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Linaclotide, a guanylate cyclase C agonist, was administered to adenine-induced renal failure (RF) mice and changes in renal function and levels of gut-derived uremic toxins, as well as the gut microbiota community, were analyzed using metabolomic and metagenomic methods to reveal its cardiorenal effect.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Linaclotide decreased the plasma levels of TMAO at a clinically used low dose of 10\u2009\u03bcg\/kg in the adenine-induced RF mouse model. At a high concentration of 100\u2009\u03bcg\/kg, linaclotide clearly improved renal function and reduced the levels of various uremic toxins. A reduction in TMAO levels following linaclotide treatment was also observed in a choline-fed pro-atherosclerotic model. Linaclotide ameliorated renal inflammation and fibrosis and cardiac fibrosis, as well as decreased the expression of collagen I, transforming growth factor-\u03b2, galectin-3 (Gal-3) and ST2 genes. Plasma levels of Gal-3 and ST2 were also reduced. Because exposure of cardiomyocytes to TMAO increased fibronectin expression, these data suggest that linaclotide reduced the levels of TMAO and various uremic toxins and may result in not only renal, but also cardiac, fibrosis. F4\/80-positive macrophages were abundant in small intestinal crypts in RF mice, and this increased expression was decreased by linaclotide. Reduced colonic claudin-1 levels were also restored by linaclotide, suggesting that linaclotide ameliorated the \u2018leaky gut\u2019 in RF mice. Metagenomic analysis revealed that the microbial order Clostridiales could be responsible for the change in TMAO levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Linaclotide reduced TMAO and uremic toxin levels and could be a powerful tool for the prevention and control of the cardiorenal syndrome by modification of the gut\u2013cardio\u2013renal axis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ndt\/gfz126","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T07:09:09Z","timestamp":1560236949000},"page":"250-264","source":"Crossref","is-referenced-by-count":41,"title":["The guanylate cyclase C agonist linaclotide ameliorates the gut\u2013cardio\u2013renal axis in an adenine-induced mouse model of chronic kidney disease"],"prefix":"10.1093","volume":"35","author":[{"given":"Fumika","family":"Nanto-Hara","sequence":"first","affiliation":[{"name":"Department of Medical Science, Tohoku University Graduate School of Biomedical Engineering , Sendai,","place":["Japan"]},{"name":"Department of Anatomy, Tohoku University Graduate School of Medicine , Sendai,","place":["Japan"]},{"name":"Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine , Sendai,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitomi","family":"Kanemitsu","sequence":"additional","affiliation":[{"name":"Laboratory of Oncology, Pharmacy Practice and Sciences, Tohoku University Graduate School of Pharmaceutical Sciences , Sendai,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Institute for Advanced Biosciences, Keio University , Tsuruoka,","place":["Japan"]},{"name":"Intestinal Microbiota Project, Kanagawa Institute of Industrial Science and Technology , Kawasaki,","place":["Japan"]},{"name":"Transborder Medical Research Center, University of Tsukuba , Tsukuba,","place":["Japan"]},{"name":"PRESTO, Japan Science and Technology Agency , Kawaguchi,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine , Sendai,","place":["Japan"]},{"name":"Department of Clinical Biology and Hormonal Regulation, Tohoku University Graduate School of Medicine , Sendai,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Asaji","sequence":"additional","affiliation":[{"name":"Laboratory of Oncology, Pharmacy Practice and Sciences, Tohoku University Graduate School of Pharmaceutical Sciences , Sendai,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Saigusa","sequence":"additional","affiliation":[{"name":"Department of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University , Sendai,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Iwasaki","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine , Sendai,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Jung","family":"Ho","sequence":"additional","affiliation":[{"name":"Department of Medical Science, Tohoku University Graduate School of Biomedical Engineering , Sendai,","place":["Japan"]},{"name":"Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine , Sendai,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eikan","family":"Mishima","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine , Sendai,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Medical Science, Tohoku University Graduate School of Biomedical Engineering , Sendai,","place":["Japan"]},{"name":"Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine , Sendai,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitose","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine , Sendai,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Tsukimi","sequence":"additional","affiliation":[{"name":"Institute for Advanced Biosciences, Keio University , Tsuruoka,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Matsuhashi","sequence":"additional","affiliation":[{"name":"Department of Medical Science, Tohoku University Graduate School of Biomedical Engineering , Sendai,","place":["Japan"]},{"name":"Division of Pediatrics, Tohoku University Graduate School of Medicine , Sendai,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitsugu","family":"Oikawa","sequence":"additional","affiliation":[{"name":"Department of Medical Science, Tohoku University Graduate School of Biomedical Engineering , Sendai,","place":["Japan"]},{"name":"Division of Pediatrics, Tohoku University Graduate School of Medicine , Sendai,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukako","family":"Akiyama","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine , Sendai,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Kure","sequence":"additional","affiliation":[{"name":"Division of Pediatrics, Tohoku University Graduate School of Medicine , Sendai,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Owada","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Tohoku University Graduate School of Medicine , Sendai,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Tomioka","sequence":"additional","affiliation":[{"name":"Laboratory of Oncology, Pharmacy Practice and Sciences, Tohoku University Graduate School of Pharmaceutical Sciences , Sendai,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyoshi","family":"Soga","sequence":"additional","affiliation":[{"name":"Laboratory of Oncology, Pharmacy Practice and Sciences, Tohoku University Graduate School of Pharmaceutical Sciences , Sendai,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadayoshi","family":"Ito","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine , Sendai,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Medical Science, Tohoku University Graduate School of Biomedical Engineering , Sendai,","place":["Japan"]},{"name":"Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine , Sendai,","place":["Japan"]},{"name":"Department of Clinical Biology and Hormonal Regulation, Tohoku University Graduate School of Medicine , Sendai,","place":["Japan"]},{"name":"Department of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University , Sendai,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,8,14]]},"reference":[{"key":"2025102312512687900_gfz126-B1","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/archinte.167.11.1122","article-title":"Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP)","volume":"167","author":"McCullough","year":"2007","journal-title":"Arch Intern Med"},{"key":"2025102312512687900_gfz126-B2","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1161\/CIRCRESAHA.112.278457","article-title":"Cardiorenal syndrome: the emerging role of protein-bound uremic toxins","volume":"111","author":"Lekawanvijit","year":"2012","journal-title":"Circ Res"},{"key":"2025102312512687900_gfz126-B3","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1161\/CIRCULATIONAHA.109.886473","article-title":"Cardiorenal syndrome: new perspectives","volume":"121","author":"Bock","year":"2010","journal-title":"Circulation"},{"key":"2025102312512687900_gfz126-B4","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrneph.2016.113","article-title":"Heart failure and kidney dysfunction: epidemiology, mechanisms and management","volume":"12","author":"Schefold","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"2025102312512687900_gfz126-B5","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Tang","year":"2013","journal-title":"N Engl J Med"},{"key":"2025102312512687900_gfz126-B6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","article-title":"Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk","volume":"165","author":"Zhu","year":"2016","journal-title":"Cell"},{"key":"2025102312512687900_gfz126-B7","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","article-title":"Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease","volume":"116","author":"Tang","year":"2015","journal-title":"Circ Res"},{"key":"2025102312512687900_gfz126-B8","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.kint.2017.02.011","article-title":"Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach","volume":"92","author":"Mishima","year":"2017","journal-title":"Kidney Int"},{"key":"2025102312512687900_gfz126-B9","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1681\/ASN.2014060530","article-title":"Alteration of the intestinal environment by lubiprostone is associated with amelioration of adenine-induced CKD","volume":"26","author":"Mishima","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2025102312512687900_gfz126-B10","doi-asserted-by":"crossref","first-page":"824395","DOI":"10.1155\/2015\/824395","article-title":"The consumption of bicarbonate-rich mineral water improves glycemic control","volume":"2015","author":"Murakami","year":"2015","journal-title":"Evid Based Complement Alternat Med"},{"key":"2025102312512687900_gfz126-B11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/dnares\/dst006","article-title":"Robustness of gut microbiota of healthy adults in response to probiotic intervention revealed by high-throughput pyrosequencing","volume":"20","author":"Kim","year":"2013","journal-title":"DNA Res"},{"key":"2025102312512687900_gfz126-B12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nmeth.f.303","article-title":"QIIME allows analysis of high-throughput community sequencing data","volume":"7","author":"Caporaso","year":"2010","journal-title":"Nat Methods"},{"key":"2025102312512687900_gfz126-B13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2017.10.009","article-title":"Simultaneous quantitative analysis of uremic toxins by LC-MS\/MS with a reversed-phase\/cation-exchange\/anion-exchange tri-modal mixed-mode column","volume":"1068\u20131069","author":"Kanemitsu","year":"2017","journal-title":"J Chromatogr B"},{"key":"2025102312512687900_gfz126-B14","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/hr.2010.113","article-title":"Metabolomic profiling of uremic solutes in CKD patients","volume":"33","author":"Toyohara","year":"2010","journal-title":"Hypertens Res"},{"key":"2025102312512687900_gfz126-B15","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1681\/ASN.2016060656","article-title":"Constipation and incident CKD","volume":"28","author":"Sumida","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2025102312512687900_gfz126-B16","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/s41598-018-19868-z","article-title":"Guanylate cyclase C reduces invasion of intestinal epithelial cells by bacterial pathogens","volume":"8","author":"Amarachintha","year":"2018","journal-title":"Sci Rep"},{"key":"2025102312512687900_gfz126-B17","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.cell.2015.11.055","article-title":"Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis","volume":"163","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"2025102312512687900_gfz126-B18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jacc.2013.07.087","article-title":"Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3","volume":"63","author":"Bayes-Genis","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025102312512687900_gfz126-B19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cca.2015.03.033","article-title":"Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases","volume":"445","author":"Mueller","year":"2015","journal-title":"Clin Chim Acta"},{"key":"2025102312512687900_gfz126-B20","doi-asserted-by":"crossref","first-page":"e006347","DOI":"10.1161\/JAHA.117.006347","article-title":"Trimethylamine-N-oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS signaling pathway","volume":"6","author":"Chen","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2025102312512687900_gfz126-B21","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1159\/000343886","article-title":"Uremic plasma impairs barrier function and depletes the tight junction protein constituents of intestinal epithelium","volume":"36","author":"Vaziri","year":"2012","journal-title":"Am J Nephrol"},{"key":"2025102312512687900_gfz126-B22","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1093\/ndt\/gfr624","article-title":"Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation","volume":"27","author":"Vaziri","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"2025102312512687900_gfz126-B23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000353764","article-title":"Chronic kidney disease causes disruption of gastric and small intestinal epithelial tight junction","volume":"38","author":"Vaziri","year":"2013","journal-title":"Am J Nephrol"},{"key":"2025102312512687900_gfz126-B24","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/ndt\/gfv095","article-title":"Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment","volume":"31","author":"Vaziri","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"2025102312512687900_gfz126-B25","first-page":"814","article-title":"Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors","volume":"38","author":"Li","year":"2017","journal-title":"Eur Heart J"},{"key":"2025102312512687900_gfz126-B26","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat Med"},{"key":"2025102312512687900_gfz126-B27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"2025102312512687900_gfz126-B28","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1164\/rccm.201211-1983OC","article-title":"Mechanisms of cardiac and renal dysfunction in patients dying of sepsis","volume":"187","author":"Takasu","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2025102312512687900_gfz126-B29","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbagen.2005.12.020","article-title":"Galectin-3: an open-ended story","volume":"1760","author":"Dumic","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"2025102312512687900_gfz126-B30","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","article-title":"Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction","volume":"110","author":"Sharma","year":"2004","journal-title":"Circulation"},{"key":"2025102312512687900_gfz126-B31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCHEARTFAILURE.112.971168","article-title":"Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis","volume":"6","author":"Yu","year":"2013","journal-title":"Circ Heart Fail"},{"key":"2025102312512687900_gfz126-B32","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/HYPERTENSIONAHA.115.05876","article-title":"Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension","volume":"66","author":"Martinez-Martinez","year":"2015","journal-title":"Hypertension"},{"key":"2025102312512687900_gfz126-B33","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1161\/01.CIR.0000038705.69871.D9","article-title":"Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction","volume":"106","author":"Weinberg","year":"2002","journal-title":"Circulation"},{"key":"2025102312512687900_gfz126-B34","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI30634","article-title":"IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system","volume":"117","author":"Sanada","year":"2007","journal-title":"J Clin Invest"},{"key":"2025102312512687900_gfz126-B35","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s12265-013-9459-y","article-title":"ST2 as a cardiovascular risk biomarker: from the bench to the bedside","volume":"6","author":"Januzzi","year":"2013","journal-title":"J Cardiovasc Transl Res"},{"key":"2025102312512687900_gfz126-B36","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/ki.2012.440","article-title":"The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease","volume":"83","author":"Anders","year":"2013","journal-title":"Kidney Int"},{"key":"2025102312512687900_gfz126-B37","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13299","article-title":"Linaclotide activates guanylate cyclase-C\/cGMP\/protein kinase-II-dependent trafficking of CFTR in the intestine","volume":"5","author":"Ahsan","year":"2017","journal-title":"Physiol Rep"},{"key":"2025102312512687900_gfz126-B38","doi-asserted-by":"crossref","first-page":"7205","DOI":"10.4049\/jimmunol.1002469","article-title":"Murine guanylate cyclase C regulates colonic injury and inflammation","volume":"186","author":"Steinbrecher","year":"2011","journal-title":"J Immunol"},{"key":"2025102312512687900_gfz126-B39","doi-asserted-by":"crossref","first-page":"e02210","DOI":"10.1128\/mBio.02210-15","article-title":"Resveratrol attenuates trimethylamine-N-oxide (TMAO)-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota","volume":"7","author":"Chen","year":"2016","journal-title":"MBio"},{"key":"2025102312512687900_gfz126-B40","doi-asserted-by":"crossref","first-page":"H1805","DOI":"10.1152\/ajpheart.00536.2018","article-title":"Chronic, low-dose TMAO treatment reduces diastolic dysfunction and heart fibrosis in hypertensive rats","volume":"315","author":"Huc","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2025102312512687900_gfz126-B41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cmet.2012.12.011","article-title":"Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation","volume":"17","author":"Bennett","year":"2013","journal-title":"Cell Metab"},{"key":"2025102312512687900_gfz126-B42","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1124\/jpet.112.199430","article-title":"Pharmacologic properties, metabolism, and disposition of linaclotide, a novel therapeutic peptide approved for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation","volume":"344","author":"Busby","year":"2013","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/35\/2\/250\/32360584\/gfz126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/35\/2\/250\/32360584\/gfz126.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:52:57Z","timestamp":1761238377000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/35\/2\/250\/5549874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,14]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,8,14]]},"published-print":{"date-parts":[[2020,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfz126","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,2]]},"published":{"date-parts":[[2019,8,14]]}}}